Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Med13lem1/Cya
Common Name:
Med13l-KO
Product ID:
S-KO-14807
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Med13l-KO
Strain ID
KOCMP-76199-Med13l-B6N-VA
Gene Name
Med13l
Product ID
S-KO-14807
Gene Alias
2210413I17Rik; 6330591G05Rik; 9030618F05Rik; Thrap2; Trap240L; mKIAA1025
Background
C57BL/6NCya
NCBI ID
76199
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:2670178
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Med13lem1/Cya mice (Catalog S-KO-14807) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000100816
NCBI RefSeq
NM_172424
Target Region
Exon 2
Size of Effective Region
~0.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
MED13L, a subunit of the CDK8-associated mediator complex, is crucial for transcriptional regulation, functioning as a molecular interface between RNA polymerase II and gene-specific transcription factors [6,7]. As part of the Mediator complex, it has an essential role in controlling gene expression, which is vital for normal biological processes [2].

Genetic variants in MED13L can lead to an autosomal-dominant syndrome characterized by intellectual disability/developmental delay, facial dysmorphism, and often accompanied by speech delay [1]. Siblings affected by intragenic deletion transmitted from a mosaic parent have been reported, and paternal germinal mosaicism for a missense MED13L variant can cause the related intellectual disability syndrome [2]. In individuals with MED13L-related disorder, severe motor speech impairment is common, along with language, motor, and cognitive deficits, as well as medical features like hypotonia, vision problems, and recurrent otitis media [3]. In lung cancer, radiation can trigger the disassembly of the Mediator complex via the silencing of MED13L by miR-4497, which affects epigenetic control and radiosensitivity [4]. Also, levels of Enterococcus faecalis in the gut are associated with variants in the MED13L locus, which has been linked to colorectal cancer [5]. Disease-associated MED13L variants can influence the dendritic development of cerebral cortical neurons, with some variants affecting dendritic growth and spine formation [6].

In summary, MED13L is essential for transcriptional regulation and normal biological function. Its variants are significantly associated with intellectual disability-related syndromes, speech and motor deficits, and potentially with cancer-related processes such as lung cancer radiosensitivity and colorectal cancer. Studies on MED13L-related phenotypes in humans help to understand its role in disease-associated biological processes.

References:

1. Carvalho, L M L, da Costa, S S, Campagnari, F, Koiffmann, C P, Rosenberg, C. 2021. Two novel pathogenic variants in MED13L: one familial and one isolated case. In Journal of intellectual disability research : JIDR, 65, 1049-1057. doi:10.1111/jir.12891. https://pubmed.ncbi.nlm.nih.gov/34713510/

2. Bessenyei, Beáta, Balogh, István, Mokánszki, Attila, Pfundt, Rolph, Szakszon, Katalin. 2022. MED13L-related intellectual disability due to paternal germinal mosaicism. In Cold Spring Harbor molecular case studies, 8, . doi:10.1101/mcs.a006124. https://pubmed.ncbi.nlm.nih.gov/34654706/

3. Mitchel, Marissa Weyer, Turner, Stefanie, Walsh, Lauren K, Myers, Scott M, Taylor, Cora M. 2024. MED13L-related disorder characterized by severe motor speech impairment. In Research square, , . doi:10.21203/rs.3.rs-4790993/v1. https://pubmed.ncbi.nlm.nih.gov/39257968/

4. Zhang, Nasha, Song, Yemei, Xu, Yeyang, Yu, Jinming, Yang, Ming. 2020. MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity. In Theranostics, 10, 9378-9394. doi:10.7150/thno.48247. https://pubmed.ncbi.nlm.nih.gov/32802198/

5. Qin, Youwen, Havulinna, Aki S, Liu, Yang, Inouye, Michael, Méric, Guillaume. 2022. Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort. In Nature genetics, 54, 134-142. doi:10.1038/s41588-021-00991-z. https://pubmed.ncbi.nlm.nih.gov/35115689/

6. Hamada, Nanako, Iwamoto, Ikuko, Nagata, Koh-Ichi. 2023. MED13L and its disease-associated variants influence the dendritic development of cerebral cortical neurons in the mammalian brain. In Journal of neurochemistry, 165, 334-347. doi:10.1111/jnc.15783. https://pubmed.ncbi.nlm.nih.gov/36798993/

7. Adegbola, Abidemi, Musante, Luciana, Callewaert, Bert, Kaindl, Angela M, Kalscheuer, Vera M. 2015. Redefining the MED13L syndrome. In European journal of human genetics : EJHG, 23, 1308-17. doi:10.1038/ejhg.2015.26. https://pubmed.ncbi.nlm.nih.gov/25758992/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest